Join us in welcoming Jessica Branning, Strategic Advisor, Clinical Innovation, to the RetiSpec team! Jessica is a healthcare entrepreneur & clinical research executive with over a decade of experience scaling multi therapeutic research organizations, with a focus on Alzheimer’s.
Happy #InternationalWomensDay! Today, we’re celebrating the achievements, leadership, and contributions of the women on our team and across the tech community, while continuing our work to help build a more inclusive industry. #IWD2026
At RetiSpec, we believe a better future for Alzheimer’s patients starts with early diagnosis. We're researching the use of advanced technology to detect disease biomarkers through the eye using familiar technology in clinicians' offices.
With recent breakthroughs in Alzheimer’s therapies, early detection is important for maximizing their success. At RetiSpec, our mission is to enable widespread early and accurate detection of Alzheimer’s through a simple eye exam. https://t.co/y7kDnIcpLY
With #AlzheimersAwarenessMonth coming to a close, @Eliavshaked joined @MooreintheAM to discuss how RetiSpec can help improve access to care through detection before the emergence of clinical symptoms.
🎙️ Listen to the full conversation: https://t.co/3KPeJ46tyY
“AI models thrive on really good, clean, robust data.” Chief Business Officer of Retispec
#BioHermes partner @RetiSpec was featured in @Being_Patient_ for its cutting-edge AI-powered retinal imaging to detect Alzheimer’s-related pathology. As we know, through #BioHermes001, Retispec identified many amyloid-positive individuals even when they were completely asymptomatic, showing accuracy comparable to blood-based biomarkers in those patients for whom both Retispec and blood biomarkers were available and strong agreement with amyloid PET.
We value our partnership with Retispec and are enthusiastic that they are a part of the ongoing #BioHermes002 with an aim to capture a wider range of retinal biomarkers. We took pride in the #BioHermes001 dataset being the one of the most extensively characterized cohorts in Alzheimer’s disease to date, and are energized to see how this study has enhanced Retispec’s capacity to advance scientific discovery. We look forward to what #BioHermes002 will unveil.
Check out more here: https://t.co/UCZzuGzdET
MaRS, @TIAPToronto and @OBIOscience launched Life Sciences Central, designed to support early-stage health ventures such as @NoaTherapeutics, @RetiSpec and @fluttercareinc. Network with these companies and other health tech startups through MaRS Connect.
https://t.co/2SDQaJiD34
👁️ Retinal imaging might become a fast, noninvasive tool for earlier #Alzheimers detection in everyday care settings, explains @RetiSpec Chief Business Officer @CathBornbaum
🔗 Read more on AI-powered eye exams here: https://t.co/Vm9rFPqXRB 🔗
Starting now -- Please join us live at 2 p.m. ET / 11 a.m. PT for a Being Patient conversation about how RetiSpec’s AI-powered eye exams are being developed to enable the early detection of Alzheimer’s disease!
https://t.co/aGMyl4ByA6
The future of Canadian life sciences innovation is here!
Thanks to our speakers and partners for highlighting how Life Sciences Central–by @MaRSDD, @OBIOscience and @TIAPToronto, unifies support to help you scale faster and commercialize.
https://t.co/7XBmkLONKr
The #MobileResearchUnit keeps rolling along, bringing brain health on the road. The team had a great stop at @RevelloMedical joined by #GAPNet site Axiom Brain Health!
The adventure continues in Davenport next week thanks to @Roche... stay tuned for more!
From Tel Aviv to Toronto—#innovation knows no age. What happens when Israeli ingenuity meets Canadian #healthcare? 🚀
Our Canada–#Israel Partnership for Smart Aging event brought together leaders from both countries to tackle one of today’s biggest challenges: #aging.
Smart screens. #AI brain gyms. Scent-based diagnostics. Because aging with dignity deserves 21st-century solutions 💭
This is just the beginning. Watch the highlights and see how two #innovation nations 🇮🇱🇨🇦 are shaping a smarter, healthier future—together.
Panel on the potential of blood-based biomarkers and digital assessments in transforming research and clinical practice.
Enjoying the insightful discussion from @IXICOnews, @LinusHealth , Fujirebio @RetiSpec and #GAPNet site Axiom Brain Health
This #AlzheimersAwarenessMonth, discover how neurotechnology is transforming dementia care.
🧠Join experts Catherine Bornbaum (@RetiSpec), Lia Tsotsos (@Sheridan_CER), and Shawn Paron (@AlzheimerOnt) as they explore groundbreaking solutions to empower seniors to defy #dementia.
Moderated by OBI’s Christa Studzinski, this panel discussion offers hope, innovation, and a vision for a future where dementia is met with compassion and action: https://t.co/Lamd73jDCm
#brainhealth
StartUp Health company @RetiSpec has raised $10M & inked partnerships to scale their early Alzheimer’s detection platform.
📺 Watch on StartUp Health TV ⤵️
https://t.co/wdqNnl3XAX
🧠 Join the #AlzMoonshot Community ⤵️
https://t.co/TBr7XuHBIY
#HealthTransformer#HealthMoonshot
AI-powered tools like tech from @MIMOSAdx, Linda Lifetech, @RetiSpec & @Tenomix_Inc are helping accelerating healthcare diagnostics, but adoption is lagging in Canada. Learn more on what needs to be done to allow AI be more quickly embraced in healthcare.
https://t.co/UeZrhqShqb
🎉 We're excited ot welcome John Forrest, Josh Soldo, and Chris Mirro at @veravas to our #AlzMoonshot Community! Veravas is making early neurological disease detection possible.
Join them by APPLYING by NOV 30: https://t.co/0uXwVnZR4q
#HealthTransformer#HealthMoonshot